Trial Outcomes & Findings for SuperSTAT 2.0 Noninvasive Blood Pressure Algorithm Enhancement (NCT NCT01482325)

NCT ID: NCT01482325

Last Updated: 2016-09-30

Results Overview

This was a data collection for engineering development to demonstrate SuperSTAT 2.0 NIBP software algorithm meets the engineering specifications. Engineers reviewed data produced by each blood pressure determination to work on new software algorithm in development. This was not conducted as program was terminated prematurely. Software iterations are not pre-defined.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

31 participants

Primary outcome timeframe

After each iteration of software development

Results posted on

2016-09-30

Participant Flow

Participant milestones

Participant milestones
Measure
Subjects Requiring Blood Pressure Monitoring
St. Joseph's Hospital (001), there were 21 subjects screened, of which five were screen failures and 16 subjects completed the study. Wisconsin Heart Hospital (002), there were 25 subjects screened, of which 10 were screen failures and 15 subjects completed the study. There were enrollment criteria followed by both Site 001 and Site 002 that were provided by the study's GEHC engineer in order to test the SuperSTAT algorithm. Each set of subjects enrolled under the required enrollment criteria were tested by the GEHC engineer.
Overall Study
STARTED
31
Overall Study
COMPLETED
31
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

SuperSTAT 2.0 Noninvasive Blood Pressure Algorithm Enhancement

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Subjects Requiring Blood Pressure Monitoring
n=31 Participants
Any subject (neonate-adult) requiring hospital or clinic blood pressure monitoring Blood pressure monitoring with GE Healthcare DASH2500 Patient Monitor: 10-20 Non-Invasive Blood Pressure readings on investigational software in the DASH2500 Patient Monitor
Age, Continuous
48.49 years
STANDARD_DEVIATION 32.74 • n=5 Participants
Sex: Female, Male
Female
18 Participants
n=5 Participants
Sex: Female, Male
Male
13 Participants
n=5 Participants

PRIMARY outcome

Timeframe: After each iteration of software development

Population: Subject analysis was not performed because study was prematurely terminated. Work on the project ceased when it was terminated.The study was intended to have the engineers review data produced by each blood pressure determination to work on new software algorithm in development. This was not and will not be conducted.

This was a data collection for engineering development to demonstrate SuperSTAT 2.0 NIBP software algorithm meets the engineering specifications. Engineers reviewed data produced by each blood pressure determination to work on new software algorithm in development. This was not conducted as program was terminated prematurely. Software iterations are not pre-defined.

Outcome measures

Outcome data not reported

Adverse Events

Subjects Requiring Blood Pressure Monitoring

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Global Research Manager

GE Healthcare

Phone: 414 721 2423

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place